Lidbree

Lidocaine, the active ingredient in Lidbree, is a local anesthetic presented as a sterile solution for intrauterine use. It provides targeted numbness to reduce discomfort during gynecologic procedures such as hysteroscopy, IUD insertion, and endometrial biopsy. GNH USA supplies Lidbree as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Lidocaine is used to provide local anesthesia in the uterine cavity for various gynecologic procedures.

Diagnostic hysteroscopy: reduces procedural pain and improves patient tolerance. Intrauterine device (IUD) insertion: facilitates pain control during placement. Endometrial biopsy: minimizes discomfort while obtaining tissue samples.

Lidocaine may cause a range of adverse reactions when administered intrauterinely.

Common Side Effects: - Uterine cramping during or after administration. - Vaginal bleeding or spotting. - Nausea or mild gastrointestinal upset. - Dizziness or light‑headedness.

Serious or Rare Side Effects: - Allergic reaction (anaphylaxis) presenting with rash, swelling, or respiratory distress. - Cardiac arrhythmia or conduction abnormalities. - Seizures due to systemic toxicity.

Lidocaine should be used with careful consideration of patient history and clinical setting. - Allergy assessment: avoid in individuals with known lidocaine hypersensitivity. - Cardiac monitoring: exercise caution in patients with conduction disorders or arrhythmias. - Dose minimization: employ the lowest effective volume to limit systemic exposure. - Concomitant anesthetics: do not combine with other local anesthetics without specialist guidance. - Storage: Store below 25°C: keep in original packaging, protect from moisture.

Lidocaine can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may raise plasma lidocaine levels and increase toxicity. - CYP3A4 inhibitors (e.g., ketoconazole, cimetidine): can reduce metabolic clearance, leading to accumulation.

Moderate Interactions (Monitor Closely): - Epinephrine-containing solutions: may prolong lidocaine effect and increase local concentration. - Other local anesthetics: additive toxicity risk if used concurrently. - Loop diuretics: may elevate systemic lidocaine concentrations by reducing renal clearance.